The Swiss medical company Endosense has enrolled the initial patients for the first study of its EFICAS series, the EFFICAS 1 in Prague, Czech Republic-based Na Homolce Hospital.
The medical technology firm CardioMEMS is commercializing its proprietary wireless communication and sensing technology developed for the human body.
A privately held life sciences vendor NanoStrings that markets a total solution for identifying and counting large target molecules sets in biological samples, has been awarded the ISO 13485:2003 certification that is a medical devices quality standard recognized internationally.
The coffee rings phenomenon could increase the sensitivity of biosensors. This phenomenon can be noticed when coffee is spilled on a table and observing the spot where the spilled coffee has evaporated.
Polytechnic Institute of New York University’s (NYU-Poly) biological and chemical science professor Dr. Kalle Levon has been able to conceptualize a point-of-care hand held gadget for detecting infectious diseases utilizing a patented biosensor of the floating gate field effect transistor (FGFET) category.
Intelligent implant systems developer MicroCHIPS’ Illume product has received the Gold award in the science and medical domain as an appreciation to the advantages it will offer to diabetes patients who need to intensively monitor their blood sugar for staying healthy.
PositiveID and RECEPTORS who is PositiveID’s development partner, have crossed a major stage towards the development of the RFID microchip for in vivo glucose-sensing application for detecting the levels of glucose in the body.
The multispectral imaging biometrics firm Lumidigm has recently launched its cost-effective and compact Mercury Series fingerprint sensors. The multispectral imaging biometric technology enables fast acquisition of better images under all environmental conditions and for all persons.
A biosensor chip capable of identifying proteins that are unique to particular diseases has been jointly developed by the Fujitsu Laboratories of Japan and scientists at the Technische Universitaet Muenchen (TUM).
The report on Noninvasive Glucose Monitors from Research and Markets provides useful data and information related to quantitative and qualitative benchmarks and measures in the glucose monitor market.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.